A logistic regression model predicting high axillary tumour burden in early breast cancer patients
Sign Up to like & getrecommendations! Published in 2017 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-017-1737-8
Abstract: PurposeAs elective axillary dissection is loosing ground for early breast cancer (BC) patients both in terms of prognostic and therapeutic power, there is a growing interest in predicting patients with (nodal) high tumour burden (HTB),… read more here.
Keywords: tumour burden; logistic regression; early breast; breast cancer ... See more keywords
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Sign Up to like & getrecommendations! Published in 2017 at "Nature"
DOI: 10.1038/nature22079
Abstract: Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human melanoma, most patients do not experience durable clinical benefit. Pre-existing T-cell infiltration and/or the presence of PD-L1 in tumours… read more here.
Keywords: tumour burden; cell; response; cell invigoration ... See more keywords
Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection
Sign Up to like & getrecommendations! Published in 2019 at "Melanoma Research"
DOI: 10.1097/cmr.0000000000000481
Abstract: This study aimed to investigate the sentinel lymph node (SLN) tumour burden to predict the non-SLN positivity rate and the survival of melanoma patients to evaluate whether SLN microstaging could predict the prognosis, similar to… read more here.
Keywords: lymph node; melanoma; non sln; tumour burden ... See more keywords
Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method
Sign Up to like & getrecommendations! Published in 2017 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000000654
Abstract: Purpose The purpose of this study was to test a method of quantifying skeletal tumour burden with 18F-NaF PET/CT. Patients and methods We retrospectively reviewed the charts of 117 patients who underwent 18F-NaF PET/CT for… read more here.
Keywords: tumour burden; 18f naf; naf pet; skeletal tumour ... See more keywords
Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Haematology"
DOI: 10.1111/bjh.15513
Abstract: The treatment of low‐tumour burden follicular lymphoma (LTBFL) remains a challenge. Rituximab‐based strategies may be improved by adding chemotherapy. This Lymphoma Study Association multicentre phase II study assessed rituximab and bendamustine in 63 patients with… read more here.
Keywords: tumour burden; lymphoma; low tumour; study ... See more keywords
Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T-cell lymphoma.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of haematology"
DOI: 10.1111/bjh.18824
Abstract: In this prospective study, we aimed to evaluate the utility of circulating tumour DNA (ctDNA) in peripheral T-cell lymphomas (PTCLs). Plasma cell-free DNA (cfDNA) was obtained, and the mutational profile was assessed in 47 patients… read more here.
Keywords: tumour burden; tumour dna; cell; circulating tumour ... See more keywords
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14133262
Abstract: Simple Summary The initial tumour burden is a strong and well-known prognostic factor in oncology. A systematic review was performed to examine if and how the initial tumour burden is reported in phase III clinical… read more here.
Keywords: clinical trials; disease; iii clinical; tumour burden ... See more keywords